SCHEMBL12836702

SCHEMBL12836702

CCOC(=O)CC(C)c1ccc(C=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.47
LTB4R Q15722 1/20 0.44
LTB4R2 Q9NPC1 1/20 0.44
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 3/20 0.43
HTT P42858 1/20 0.43
ALDH1A3 P47895 1/20 0.43
STAT3 P40763 1/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
ACHE P22303 1/20 0.42
GRIA4 P48058 1/20 0.41
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 2/20 0.40
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12836701 1.00 TYR (0.47) TYRLTB4RLTB4R2ALDH1A1KDM4E
SCHEMBL12836700 1.00 TYR (0.47) TYRLTB4RLTB4R2ALDH1A1KDM4E
SCHEMBL12883167 0.85 ACHE (0.59) LTB4RLTB4R2ALDH1A1KDM4EHTT
SCHEMBL21199753 0.85 ALDH1A1 (0.50) LTB4RLTB4R2ALDH1A1KDM4EHTT
SCHEMBL12883163 0.85 ACHE (0.59) LTB4RLTB4R2ALDH1A1KDM4EHTT
SCHEMBL12883164 0.85 ACHE (0.59) LTB4RLTB4R2ALDH1A1KDM4EHTT
SCHEMBL13715441 0.83 KMT2A (0.49) LTB4RLTB4R2ALDH1A1KDM4EHTT
SCHEMBL3665975 0.83 KMT2A (0.49) LTB4RLTB4R2ALDH1A1KDM4EHTT
SCHEMBL13715515 0.83 KMT2A (0.49) LTB4RLTB4R2ALDH1A1KDM4EHTT
SCHEMBL22230670 0.82 KMT2A (0.47) LTB4RLTB4R2ALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011034849-A1 NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS AURIMED PHARMA, INC. (US) 2011-03-24 WO disclosed